Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Bone resorption predicts for skeletal complications in metastatic bone disease
2003
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment
1996
Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis
1990
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment
1990
Calcium and Vitamin D in Sarcoidosis: How to Assess and Manage
2010
The Role of Calcitonin in the Development and Treatment of Osteoporosis*
1987
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change
2003 Standout
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
2002
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
1998
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1992
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Clinical applications of quinone-containing alkylating agents
2000
Osteoporosis: now and the future
2011 Standout
Effect of calcitonin on bone mass and fracture rates
1991
Sarcoidosis
2013 Standout
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
1999
The Epidemiology of Distal Radius Fractures
2012 Standout
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Interstitial lung disease guideline
2008
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women
2002
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Complex Regional Pain Syndrome Type I: Use of the International Association for the Study of Pain Diagnostic Criteria Defined in 1994
2002
Cancer treatment and survivorship statistics, 2012
2012 Standout
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
2010
Osteoporosis after solid organ and bone marrow transplantation
2003
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Glucocorticoid-induced osteoporosis
2000
Ectopic fat, insulin resistance and non-alcoholic fatty liver disease
2013
Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer
1999
NAFLD: A multisystem disease
2015 Standout
Validation of proposed diagnostic criteria (the “Budapest Criteria”) for Complex Regional Pain Syndrome
2010 Standout
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial
1995
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Primary Biliary Cirrhosis
2011 Standout
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: A Comparison of Calcitriol, Vitamin D Plus Calcium, and Alendronate Plus Calcium
2003
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
2000
Parenteral Calcitonin for Metabolic Bone Disease Associated With Primary Biliary Cirrhosis
1994
Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial
2006
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Gastrointestinal and Nutritional Problems Occur Frequently Throughout Life in Girls and Women With Rett Syndrome
2012
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
1996
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Skeletal complications of malignancy
1997 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Bisphosphonates for steroid-induced osteoporosis
2016
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of S. Gonnelli being referenced
Usefulness of Ultrasound in Sudeck's Atrophy of the Foot
1998
Heel Ultrasonography in Monitoring Alendronate Therapy: A Four-Year Longitudinal Study
2002
Prevention of Corticosteroid-Induced Osteoporosis with Alendronate in Sarcoid Patients
1997
Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C
1993
Bone ultrasonography at phalanxes in patients with Rett syndrome: A 3-year longitudinal study
2007
Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study
1986
Antidiabetic therapy effects on bone metabolism and fracture risk
2013
Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
1993
The Usefulness of Bone Turnover in Predicting the Response to Transdermal Estrogen Therapy in Postmenopausal Osteoporosis
1997